Table 1.
Patient Characteristics
| Median Age (range) | 48 years (19-67) | |
|---|---|---|
| Male Sex | 57% | |
| Malignancy | ||
| AML | 33 (34%) | |
| Non-Hodgkin lymphoma | 19 (19%) | |
| Hodgkin lymphoma | 8 (8%) | |
| Aplastic Anemia | 7 (7%) | |
| MDS | 12 (12%) | |
| CLL/PLL | 6 (6%) | |
| ALL | 6 (6%) | |
| CML | 4 (4%) | |
| Other | 3 (3%) | |
| Transplant Risk | ||
| Standard | 18 (20%) | |
| High Risk | 70 (80%) | |
| Conditioning Regimen | ||
| Reduced Intensity | 70 (71%) | |
| Myeloablative | 28 (29%) | |
| GVHD Prophylaxis | ||
| Sirolimus-based | 63 (64%) | |
| Non-sirolimus Based | 35 (36%) | |
Standard Risk: AML/ALL CR 1, MDS RA/RARS, CML CP1
High Risk: All others, excluding aplastic anemia and lymphoma